Effective 3 April 2025, Novo Nordisk will undergo key changes in its Executive Management. Camilla Sylvest, a long-time leader with 28 years at t ...

Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danish pharma’s chief scientific officer has insisted that the changes aren’t primarily about laying off staff.

With as much as $17 billion in sales in 2024, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). This Scandinavian economic behemoth ...

Sweden is part of the Nordic region in northern Europe, together with the countries of Denmark, Finland, Iceland and Norway. Sweden is large in size, small in population. Sweden is a democracy and a ...

This is why celebrities often blur their homes on Google Maps, so that stalkers and thieves can't get a good look at it. And you can do the same. If your house is visible on Street View ...

Sweden, Austria and Israeel are leading the current betting odds to win the competition come May. Alright, buckle up Eurovision fans, because the 2025 contest is already shaping up to be a wild ...

Located on a blustery plateau just south of the Arctic Circle in Sweden, Markbygden Ett became the crown jewel of Europe’s largest onshore wind development when it went online late last decade.

Sweden's security service said Russia's activities were mainly aimed at undermining Nato cohesion Russia poses the greatest threat to Sweden due to its aggressive attitude towards the West, the ...

Novo Nordisk launched a direct-to-consumer program last week to sell Wegovy at a reduced price for people who are uninsured or insured on commercial plans that don't cover the obesity drug. Through ...

Novo Nordisk A/S' CagriSema disappointed investors again, but today's update should not have surprised anyone. The flexible dosing protocol in the REDEFINE trials likely led to suboptimal efficacy ...

Roche Holding AG hired a senior executive from rival Novo Nordisk A/S as the Swiss drugmaker prepares to enter the hyper-competitive market for obesity drugs. Morten Lammert will join Roche as its ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in Novo Nordisk fell on Monday on a second set of worse than expected trial results for the latest ...